Northern Trust
BBNX

Northern Trust’s Beta Bionics BBNX Stock Holding History

Northern Trust’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.96M Buy
295,818
+11,365
+4% +$168K ﹤0.01% 2752
2025
Q4 		$8.67M Sell
284,453
-13,607
-5% -$363K ﹤0.01% 2158
2025
Q3 		$5.92M Buy
298,060
+202,807
+213% +$3.56M ﹤0.01% 2401
2025
Q2 		$1.39M Sell
95,253
-16,234
-15% -$230K ﹤0.01% 3208
2025
Q1 		$1.36M Buy
+111,487
New +$2.08M ﹤0.01% 3128

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Northern Trust's BBNX Position: Q1 2026 in Review

Northern Trust increased its Beta Bionics (BBNX) stake by 4% in Q1 2026, buying an estimated $168K and bringing the position to 295,818 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #2752.

Northern Trust first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $8.67M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Northern Trust held 295,818 shares of Beta Bionics worth $2.96M as of Q1 2026.
  • Northern Trust bought 11,365 Beta Bionics shares in Q1 2026, an estimated $168K.
  • Beta Bionics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2752 holding.
  • Northern Trust first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Northern Trust's Beta Bionics position peaked at $8.67M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.